Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort.
(2015) In BMC Medicine 13(1).- Abstract
- Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is difficult to diagnose and has limited treatment options with a low survival rate. Aside from a few key risk factors, such as hepatitis, high alcohol consumption, smoking, obesity, and diabetes, there is incomplete etiologic understanding of the disease and little progress in identification of early risk biomarkers.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8035107
- author
- Fages, Anne
; Duarte-Salles, Talita
; Stepien, Magdalena
; Ferrari, Pietro
; Fedirko, Veronika
; Pontoizeau, Clément
; Trichopoulou, Antonia
; Aleksandrova, Krasimira
; Tjønneland, Anne
; Olsen, Anja
; Clavel-Chapelon, Françoise
; Boutron-Ruault, Marie-Christine
; Severi, Gianluca
; Kaaks, Rudolf
; Kuhn, Tilman
; Floegel, Anna
; Boeing, Heiner
; Lagiou, Pagona
; Bamia, Christina
; Trichopoulos, Dimitrios
; Palli, Domenico
; Pala, Valeria
; Panico, Salvatore
; Tumino, Rosario
; Vineis, Paolo
; Bueno-de-Mesquita, H Bas
; Peeters, Petra H
; Weiderpass, Elisabete
; Agudo, Antonio
; Molina-Montes, Esther
; Huerta, José María
; Ardanaz, Eva
; Dorronsoro, Miren
; Sjöberg, Klas
LU
; Ohlsson, Bodil
LU
; Khaw, Kay-Tee
; Wareham, Nick
; Travis, Ruth C
; Schmidt, Julie A
; Cross, Amanda
; Gunter, Marc
; Riboli, Elio
; Scalbert, Augustin
; Romieu, Isabelle
; Elena-Herrmann, Benedicte
and Jenab, Mazda
(Less) - organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BMC Medicine
- volume
- 13
- issue
- 1
- article number
- 242
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:26399231
- wos:000361784500001
- scopus:84959897574
- pmid:26399231
- ISSN
- 1741-7015
- DOI
- 10.1186/s12916-015-0462-9
- language
- English
- LU publication?
- yes
- id
- a5541f47-3f80-4a43-9c6a-63fd38053ffc (old id 8035107)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26399231?dopt=Abstract
- date added to LUP
- 2016-04-01 14:43:17
- date last changed
- 2023-04-07 02:04:44
@article{a5541f47-3f80-4a43-9c6a-63fd38053ffc,
abstract = {{Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is difficult to diagnose and has limited treatment options with a low survival rate. Aside from a few key risk factors, such as hepatitis, high alcohol consumption, smoking, obesity, and diabetes, there is incomplete etiologic understanding of the disease and little progress in identification of early risk biomarkers.}},
author = {{Fages, Anne and Duarte-Salles, Talita and Stepien, Magdalena and Ferrari, Pietro and Fedirko, Veronika and Pontoizeau, Clément and Trichopoulou, Antonia and Aleksandrova, Krasimira and Tjønneland, Anne and Olsen, Anja and Clavel-Chapelon, Françoise and Boutron-Ruault, Marie-Christine and Severi, Gianluca and Kaaks, Rudolf and Kuhn, Tilman and Floegel, Anna and Boeing, Heiner and Lagiou, Pagona and Bamia, Christina and Trichopoulos, Dimitrios and Palli, Domenico and Pala, Valeria and Panico, Salvatore and Tumino, Rosario and Vineis, Paolo and Bueno-de-Mesquita, H Bas and Peeters, Petra H and Weiderpass, Elisabete and Agudo, Antonio and Molina-Montes, Esther and Huerta, José María and Ardanaz, Eva and Dorronsoro, Miren and Sjöberg, Klas and Ohlsson, Bodil and Khaw, Kay-Tee and Wareham, Nick and Travis, Ruth C and Schmidt, Julie A and Cross, Amanda and Gunter, Marc and Riboli, Elio and Scalbert, Augustin and Romieu, Isabelle and Elena-Herrmann, Benedicte and Jenab, Mazda}},
issn = {{1741-7015}},
language = {{eng}},
number = {{1}},
publisher = {{BioMed Central (BMC)}},
series = {{BMC Medicine}},
title = {{Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort.}},
url = {{http://dx.doi.org/10.1186/s12916-015-0462-9}},
doi = {{10.1186/s12916-015-0462-9}},
volume = {{13}},
year = {{2015}},
}